Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

IGF-1 LR3 and MGF Interaction: Monitor | Peptide Database

Can you take IGF-1 LR3 with MGF? Monitor interaction (90% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

IGF-1 LR3

Modified Growth Factor Analog | Muscle Growth

Functions as a full IGF-1 receptor agonist activating PI3K/Akt/mTOR and MAPK/ERK pathways. The modifications prevent protein sequestration, maintaining elevated free circulating levels for extended anabolic effects.

MGF

Mechano Growth Factor | IGF-1 Splice Variant

Activates muscle satellite stem cells via receptor binding, stimulating MAPK/ERK signaling. Enhances protein synthesis and promotes muscle fiber repair.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take IGF-1 LR3 with MGF?

Yes, but with caution. Both target IGF-1 pathways; combining risks receptor overstimulation. Regular monitoring is advised.

Is IGF-1 LR3 and MGF safe together?

Based on documented research, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting. Monitor accordingly.

What are the interactions between IGF-1 LR3 and MGF?

Both target IGF-1 pathways; combining risks receptor overstimulation. This assessment has 90% confidence and is based on documented research data.

How should I time IGF-1 LR3 and MGF?

IGF-1 LR3 has a half-life of 20-30 hours and MGF has a half-life of ~5-7 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question